EP1633797A4 - Biodegradable branched polylactide derivativescapable of forming polymeric micelles, and their preparation method and use - Google Patents
Biodegradable branched polylactide derivativescapable of forming polymeric micelles, and their preparation method and useInfo
- Publication number
- EP1633797A4 EP1633797A4 EP04808305A EP04808305A EP1633797A4 EP 1633797 A4 EP1633797 A4 EP 1633797A4 EP 04808305 A EP04808305 A EP 04808305A EP 04808305 A EP04808305 A EP 04808305A EP 1633797 A4 EP1633797 A4 EP 1633797A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- preparation
- derivativescapable
- forming polymeric
- polymeric micelles
- biodegradable branched
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000747 poly(lactic acid) Polymers 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000000693 micelle Substances 0.000 title 1
- 239000004626 polylactic acid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
- C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
- C08G63/08—Lactones or lactides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/78—Preparation processes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/91—Polymers modified by chemical after-treatment
- C08G63/912—Polymers modified by chemical after-treatment derived from hydroxycarboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Polyesters Or Polycarbonates (AREA)
- Biological Depolymerization Polymers (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030087459A KR20050054129A (en) | 2003-12-04 | 2003-12-04 | Biodegradable branched polylactide derivatives capable of forming polymeric micelles, and their preparation method and use |
PCT/KR2004/003174 WO2005054333A1 (en) | 2003-12-04 | 2004-12-03 | Biodegradable branched polylactide derivativescapable of forming polymeric micelles, and their preparation method and use |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1633797A1 EP1633797A1 (en) | 2006-03-15 |
EP1633797A4 true EP1633797A4 (en) | 2009-05-13 |
EP1633797B1 EP1633797B1 (en) | 2010-01-27 |
Family
ID=36642449
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04808305A Active EP1633797B1 (en) | 2003-12-04 | 2004-12-03 | Biodegradable branched polylactide derivativescapable of forming polymeric micelles, and their preparation method and use |
Country Status (13)
Country | Link |
---|---|
US (1) | US8021652B2 (en) |
EP (1) | EP1633797B1 (en) |
JP (2) | JP2006526053A (en) |
KR (2) | KR20050054129A (en) |
CN (1) | CN100386358C (en) |
AT (1) | ATE456600T1 (en) |
AU (1) | AU2004295264B2 (en) |
CA (1) | CA2523989C (en) |
DE (1) | DE602004025344D1 (en) |
HK (1) | HK1089459A1 (en) |
MX (1) | MXPA05011584A (en) |
NZ (1) | NZ543001A (en) |
WO (1) | WO2005054333A1 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8778322B2 (en) * | 2001-10-18 | 2014-07-15 | Samyang Biopharmaceuticals Corporation | pH responsive biodegradable polylactic acid derivatives forming polymeric micelles and uses thereof for poorly water soluble drug delivery |
EP1367080A1 (en) | 2002-05-29 | 2003-12-03 | Hycail B.V. | Hyperbranched poly(hydroxycarboxylic acid) polymers |
JP2012233208A (en) * | 2005-10-03 | 2012-11-29 | Dai Ichi Kogyo Seiyaku Co Ltd | Functional filler and resin composition containing same |
US7794495B2 (en) * | 2006-07-17 | 2010-09-14 | Advanced Cardiovascular Systems, Inc. | Controlled degradation of stents |
US8802126B2 (en) * | 2008-06-30 | 2014-08-12 | Abbott Cardiovascular Systems Inc. | Polyester implantable medical device with controlled in vivo biodegradability |
US8137818B2 (en) * | 2008-07-28 | 2012-03-20 | Tate & Lyle Ingredients Americas Llc | Poly(lactic acid)-containing compositions for use in imparting oil, grease, or water resistance to paper |
JP5567581B2 (en) * | 2008-11-07 | 2014-08-06 | サムヤン バイオファーマシューティカルズ コーポレイション | High-purity polylactic acid, salt or derivative thereof, and purification method thereof |
EP2201935B1 (en) * | 2008-12-26 | 2020-07-08 | Samyang Biopharmaceuticals Corporation | Polymeric micelle composition containing a poorly soluble drug and preparation method of the same |
ES2379676T3 (en) * | 2009-04-23 | 2012-04-30 | Vivoxid Oy | Biocompatible composite material and its use |
FR2967416B1 (en) * | 2010-11-15 | 2012-12-21 | Ipsen Pharma Sas | PROCESS FOR THE PREPARATION OF VARIOUS ARCHITECTURE POLYMERS AND AMIDE AMORCING |
KR101467275B1 (en) * | 2011-12-19 | 2014-12-02 | 주식회사 삼양바이오팜 | Composition of biodegradable polymer microparticles with high dispersibility and method for preparing the same |
WO2013124867A1 (en) | 2012-02-21 | 2013-08-29 | Amrita Vishwa Vidyapeetham University | Polymer - polymer or polymer - protein core - shell nano medicine loaded with multiple drug molecules |
FR2995901B1 (en) * | 2012-09-21 | 2015-08-14 | Inst Corps Gras Etudes Et Rech S Tech Iterg | NOVEL BIOSOURCES PRE-POLYMERS AND THEIR USES FOR THE PREPARATION OF USEFUL POLYMERS AS ADDITIVES IN A POLY (LACTIC ACID) MATRIX |
JP6164860B2 (en) * | 2013-02-15 | 2017-07-19 | 三井化学株式会社 | Polymandelic acid |
WO2014141289A1 (en) | 2013-03-12 | 2014-09-18 | Amrita Vishwa Vidyapeetham University | Photo - chemo composition on the basis of microcapsules with a core -shell structure |
CN104292444B (en) * | 2014-10-15 | 2016-06-29 | 四川大学 | There is the synthetic method of the class meteor plektron polylactic acid of controllable precise molecular structure |
US20230087601A1 (en) * | 2020-02-21 | 2023-03-23 | Natureworks Llc | Cosmetic compositions containing low molecular weight amorphous grade polylactic acid resin |
KR102460624B1 (en) | 2020-09-22 | 2022-10-28 | 가톨릭대학교 산학협력단 | A drug delivery system capable of controlled drug release and x-ray imaging and use thereof |
CN114437319B (en) * | 2022-01-12 | 2023-08-15 | 青岛科技大学 | Method for rapidly and controllably preparing glycolide-lactide copolymer by using plug flow reactor |
CN114773581B (en) * | 2022-04-25 | 2024-06-25 | 万华化学集团股份有限公司 | Polylactic acid composition and preparation method thereof |
CN115260478B (en) * | 2022-07-19 | 2024-02-02 | 绍兴文理学院 | Preparation method and application of high-strength high-toughness polylactic acid copolymer |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3065384B2 (en) * | 1991-06-05 | 2000-07-17 | 旭硝子株式会社 | Method for producing lactide polymer |
JPH06322805A (en) * | 1993-05-13 | 1994-11-22 | Matsushita Electric Ind Co Ltd | Toilet with image recognizing device |
US5543158A (en) | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
SI9620107A (en) | 1995-08-10 | 1998-10-31 | Kazunori Kataoka | Block polymer having functional groups at both ends |
KR0180334B1 (en) | 1995-09-21 | 1999-03-20 | 김윤 | Drug messenger using el-2l-2 micelle and method for sealing drug to it |
EP0895517B1 (en) * | 1996-04-23 | 2004-11-17 | Ipsen Manufacturing Ireland Limited | Acidic polylactic polymers |
JPH10110019A (en) * | 1996-10-08 | 1998-04-28 | Kazunori Kataoka | Stabilized polymeric micelle and its use as carrier for biologically active substance |
US6461631B1 (en) * | 1999-11-16 | 2002-10-08 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
JP4565290B2 (en) * | 1999-12-01 | 2010-10-20 | 東洋紡績株式会社 | Oxyacid aliphatic polyester having high hydroxyl group concentration and oxyacid aliphatic polyester composition |
EP1306013A1 (en) * | 2001-03-28 | 2003-05-02 | Hycail B.V. | Biodegradable gum base |
US8778322B2 (en) | 2001-10-18 | 2014-07-15 | Samyang Biopharmaceuticals Corporation | pH responsive biodegradable polylactic acid derivatives forming polymeric micelles and uses thereof for poorly water soluble drug delivery |
KR100492805B1 (en) | 2001-10-18 | 2005-06-07 | 주식회사 삼양사 | Polymeric micelle composition with improved stability |
KR100531269B1 (en) | 2001-12-04 | 2005-11-28 | 주식회사 삼양사 | Polymeric compositions for forming micelles or nanoparticles which are stable in aqueous solution |
CA2523987C (en) * | 2003-10-10 | 2009-08-04 | Samyang Corporation | Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery |
-
2003
- 2003-12-04 KR KR1020030087459A patent/KR20050054129A/en active Search and Examination
-
2004
- 2004-12-03 EP EP04808305A patent/EP1633797B1/en active Active
- 2004-12-03 JP JP2006508549A patent/JP2006526053A/en active Pending
- 2004-12-03 MX MXPA05011584A patent/MXPA05011584A/en active IP Right Grant
- 2004-12-03 WO PCT/KR2004/003174 patent/WO2005054333A1/en active IP Right Grant
- 2004-12-03 US US10/554,637 patent/US8021652B2/en active Active
- 2004-12-03 CN CNB2004800114079A patent/CN100386358C/en active Active
- 2004-12-03 AT AT04808305T patent/ATE456600T1/en not_active IP Right Cessation
- 2004-12-03 AU AU2004295264A patent/AU2004295264B2/en active Active
- 2004-12-03 NZ NZ543001A patent/NZ543001A/en unknown
- 2004-12-03 DE DE602004025344T patent/DE602004025344D1/en active Active
- 2004-12-03 KR KR1020057018873A patent/KR100724719B1/en active IP Right Grant
- 2004-12-03 CA CA2523989A patent/CA2523989C/en active Active
-
2006
- 2006-09-05 HK HK06109845.2A patent/HK1089459A1/en unknown
-
2009
- 2009-07-07 JP JP2009161156A patent/JP5579406B2/en active Active
Non-Patent Citations (1)
Title |
---|
No further relevant documents disclosed * |
Also Published As
Publication number | Publication date |
---|---|
JP2009263680A (en) | 2009-11-12 |
WO2005054333A1 (en) | 2005-06-16 |
EP1633797A1 (en) | 2006-03-15 |
DE602004025344D1 (en) | 2010-03-18 |
JP2006526053A (en) | 2006-11-16 |
AU2004295264A1 (en) | 2005-06-16 |
KR20050054129A (en) | 2005-06-10 |
US20070003625A1 (en) | 2007-01-04 |
KR100724719B1 (en) | 2007-06-04 |
CA2523989A1 (en) | 2005-06-16 |
CA2523989C (en) | 2009-01-27 |
MXPA05011584A (en) | 2005-12-14 |
US8021652B2 (en) | 2011-09-20 |
CN1780868A (en) | 2006-05-31 |
NZ543001A (en) | 2009-09-25 |
KR20060009831A (en) | 2006-02-01 |
AU2004295264B2 (en) | 2009-10-29 |
CN100386358C (en) | 2008-05-07 |
HK1089459A1 (en) | 2006-12-01 |
ATE456600T1 (en) | 2010-02-15 |
EP1633797B1 (en) | 2010-01-27 |
JP5579406B2 (en) | 2014-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1089459A1 (en) | Biodegradable branched polylactide derivativescapable of forming polymeric micelles, and their preparation method and use | |
BR0316375A (en) | Diazinopyrimidines | |
HK1089444A1 (en) | Dihydropteridinones, method for the production and use thereof in the form of drugs | |
RS65604A (en) | Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals | |
DE60024830T2 (en) | METHOD FOR PRODUCING HETEROARYL SUBSTITUTED UREA BONDING | |
ATE554062T1 (en) | METHOD FOR PRODUCING ALKYLATED SALICYLAMEDES BY A DICARBOXYLATE INTERMEDIATE | |
TNSN04199A1 (en) | Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use | |
BR0213802A (en) | Useful copolymer for the preparation of acid gels | |
ATE527000T1 (en) | BIODEGRADABLE POLYMER SYSTEM | |
MXPA02011370A (en) | Substituted iminoazines. | |
YU56302A (en) | 8,8a-dihydro-indeno/1,2-d/thiazol-derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g.anorectic agents | |
DE60232158D1 (en) | LIPOPEPTIDE STEREOISOMERS, METHOD FOR THEIR PRODUCTION AND USEFUL INTERMEDIATE PRODUCTS | |
MXPA02009643A (en) | Shortened synthesis of 3,3-diarylpropylamine derivatives. | |
MA27232A1 (en) | N-BENZOYLUREIDOCINNAMIC ACID DERIVATIVES, PREPARATION METHODS AND USES THEREOF | |
RS19504A (en) | Novel compounds and compositions as cathepsin inhibitors | |
DE50113943D1 (en) | 4-ALKOXY-CYCLOHEXAN-1-AMINO-CARBOXYLIC ACID ESTERS AND METHOD FOR THE PRODUCTION THEREOF | |
ATE297428T1 (en) | MODIFIED POLYAMIDES, COMPOSITIONS BASED ON THESE POLYAMIDES AND METHOD FOR THE PRODUCTION THEREOF | |
RS88704A (en) | Acyl-3-carboxyphenylurea derivatives, method for production and use thereof | |
IS6636A (en) | Circular ketones and their use in the construction of amino acids | |
ATE473213T1 (en) | METHOD FOR PRODUCING PHENYL-2-PYRIMIDINYL KETONES AND NEW INTERMEDIATE PRODUCTS THEREOF | |
UY26435A1 (en) | BIS-BASIC COMPOUNDS AS TRIPTASE INHIBITORS, PROCEDURE FOR THEIR PREPARATION AND USE AS MEDICINES. | |
AU2002210537A1 (en) | (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists | |
ATE372994T1 (en) | PRODUCTION OF LACTIC ACID DERIVATIVES AND THEIR APPLICATION | |
DK1257523T3 (en) | Process for preparing 3-aminoalkanoic acid esters | |
ATE260921T1 (en) | METHOD FOR PRODUCING IMIDAZO (1,2-C) (2, 3)BENZODIAZEPINES AND INTERMEDIATE PRODUCTS IN THEIR PRODUCTION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20051025 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20090415 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: RENTSCH & PARTNER Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 602004025344 Country of ref document: DE Date of ref document: 20100318 Kind code of ref document: P |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: T3 |
|
LTIE | Lt: invalidation of european patent or patent extension |
Effective date: 20100127 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100127 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100527 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100127 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100527 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100508 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100127 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100127 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100127 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100127 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100127 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100428 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100127 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100127 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100127 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100127 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100127 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100427 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20101028 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100127 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100127 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PFA Owner name: SAMYANG CORPORATION Free format text: SAMYANG CORPORATION#263, YEONJI-DONG, JONGRO-GU#SEOUL 110-725 (KR) -TRANSFER TO- SAMYANG CORPORATION#263, YEONJI-DONG, JONGRO-GU#SEOUL 110-725 (KR) |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101203 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R082 Ref document number: 602004025344 Country of ref document: DE Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAEL, DE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PUE Owner name: SAMYANG BIOPHARMACEUTICALS CORPORATION Free format text: SAMYANG HOLDINGS CORPORATION#263, YEONJI-DONG, JONGNO-GU#SEOUL 110-725 (KR) -TRANSFER TO- SAMYANG BIOPHARMACEUTICALS CORPORATION#263, YEONJI-DONG, JONGNO-GU#SEOUL 110-725 (KR) Ref country code: CH Ref legal event code: PFA Owner name: SAMYANG HOLDINGS CORPORATION Free format text: SAMYANG CORPORATION#263, YEONJI-DONG, JONGRO-GU#SEOUL 110-725 (KR) -TRANSFER TO- SAMYANG HOLDINGS CORPORATION#263, YEONJI-DONG, JONGNO-GU#SEOUL 110-725 (KR) |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: TD Effective date: 20120820 Ref country code: NL Ref legal event code: SD Effective date: 20120820 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100728 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101203 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R082 Ref document number: 602004025344 Country of ref document: DE Representative=s name: WUESTHOFF & WUESTHOFF, PATENTANWAELTE PARTG MB, DE Effective date: 20120813 Ref country code: DE Ref legal event code: R082 Ref document number: 602004025344 Country of ref document: DE Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAEL, DE Effective date: 20120813 Ref country code: DE Ref legal event code: R081 Ref document number: 602004025344 Country of ref document: DE Owner name: SAMYANG BIOPHARMACEUTICALS CORP., KR Free format text: FORMER OWNER: SAMYANG CORP., SEOUL, KR Effective date: 20120813 Ref country code: DE Ref legal event code: R081 Ref document number: 602004025344 Country of ref document: DE Owner name: SAMYANG BIOPHARMACEUTICALS CORP., KR Free format text: FORMER OWNER: SAMYANG CORP., SEOUL/SOUL, KR Effective date: 20120813 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100127 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E Free format text: REGISTERED BETWEEN 20130215 AND 20130220 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 13 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 14 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 15 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: PD Owner name: SAMYANG HOLDINGS CORPORATION; KR Free format text: DETAILS ASSIGNMENT: CHANGE OF OWNER(S), MERGE; FORMER OWNER NAME: SAMYANG BIOPHARMACEUTICALS CORPORATION Effective date: 20210827 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 602004025344 Country of ref document: DE Owner name: SAMYANG HOLDINGS CORPORATION, KR Free format text: FORMER OWNER: SAMYANG BIOPHARMACEUTICALS CORP., SEOUL, KR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E Free format text: REGISTERED BETWEEN 20211111 AND 20211117 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20230905 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20230905 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20231006 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20230905 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20240101 Year of fee payment: 20 |